CCRF Clinical Trials Projects presented perfectly in CIT 2012

永铭诚道（北京）咨询有限公司CCRF 所承担的研究项目以及相关内容将在以下场次进行呈现，敬请光临！
Clinical Trials Projects undertaken by CCRF and related contents will be presented in the following sessions.
Welcome for your Presence.

3月15日星期四 12:40 PM-1:55 PM一层多功能A厅
午间卫星会  微创主办——感受火鹰，锁定未来
主席：Martin B. Leon
共同主席：Fausto Feres, 马长生, 沈卫峰, 徐波
12:40 PM - 开场致辞
12:43 PM - FIREHAWK生物可吸收聚合物西莫罗司洗脱支架：首次人体研究、TARGET I及TARGET II试验最新进展
高润霖
12:58 PM - TARGET I试验中FIREHAWK对比XIENCE V支架的血管镜发现
陈绍良
1:13 PM - TARGET I试验中FIREHAWK支架的血管内超声发现
张瑞岩
1:28 PM - FIREHAWK单中心经验及来自TARGET系列试验的精彩病例
韩雅玲
1:43 PM - 专家讨论及听众问答

Luncheon Symposium
Sponsored by MicroPort
Experiencing FIREHAWK, Targeting the Future
12:40 PM-1:55 PM, Thursday, March 15th, 2012
Function A, Level 1, CNCC
Chairman: Martin B. Leon
Co-Chairmen: Fausto Feres, Changsheng Ma, Weifeng Shen, Bo Xu

12:40 PM - Opening Address
 
12:43 PM - FIREHAWK Bioabsorbable Polymer Sirolimus-Eluting Stent: Update on the First-in-Man, TARGET I, and TARGET II Trials
Run-Lin Gao
 
12:58 PM - Angioscopic Findings of FIREHAWK vs. XIENCE V from TARGET I Trial
Shaoliang Chen
 
1:13 PM - IVUS Findings of FIREHAWK from TARGET I Trial
Ruiyan Zhang
 
1:28 PM - Single Center Experience of FIREHAWK and Case Reviews from TARGET I and II Trials
Yaling Han
1:43 PM - Panel Discussion with Audience Q&A                                                                             

3月16日 星期五 一层多功能B厅
最新临床试验与特色研究首次公布（一）
5:00 PM - TRACK-D：评价糖尿病患者中应用瑞舒伐他汀以预防对比剂引发急性肾损伤的安全性与有效性的大规模、多中心、随机对照试验
韩雅玲
5:22 PM - DK-CRUSH III：对比双挤压支架术与裙裤支架术治疗无保护左主干末端分叉病变的多中心、随机对照试验
陈绍良

Late Breaking Clinical Trials and First Report Investigations I
5:00 PM-6:15 PM, Friday, March 16th, 2012
Function B, Level 1, CNCC
5:00 PM - TRACK-D: A Large-Scale, Multicenter, Randomized Trial Assessing the Safety and Efficacy for Rosuvastatin to Prevent Contrast-Induced Acute Kidney Injury in Patients with Diabetes
Yaling Han
5:22 PM - DK-CRUSH III: A Multicenter, Randomized Trial Comparing Double Kissing (DK) Crush vs. Culotte Stenging for the Treatment of Unprotected Distal Left Main Bifurcation Lesions
Shaoliang Chen

3月16日星期五12:40 PM-1:55 PM 一层多功能B厅
午间卫星会 吉威主办——降解到天然般的健康
1:05 PM - CREATE注册登记研究5年随访结果
韩雅玲

Luncheon Symposium
Sponsored by JW Medical
Biodegradable for Natural Health
12:40 PM-1:55 PM, Friday, March 16th, 2012
Function B, Level 1, CNCC
1:05 PM - CREATE 5-Year Update: Multi-Center Registry of EXCEL Biodegradable Polymer Drug-Eluting Stent
Yaling Han

3月17日 星期六 一层多功能B厅
最新临床试验与特色研究首次公布（二）

9:30 AM - CREATE：EXCEL生物可降解聚合物药物洗脱支架前瞻性、大规模、多中心注册登记研究 - 最终5年临床结果
韩雅玲
9:45 AM - TARGET I长支架队列：评价FIREHAWK生物可降解聚合物雷帕霉素靶向洗脱支架治疗冠状动脉长病变安全性和有效性的前瞻性、多中心研究 - 9个月造影与1年临床结果
高润霖
10:00 AM - FOCUS：FIREBIRD 2钴铬合金雷帕霉素洗脱支架前瞻性、大规模、多中心注册登记研究 - 2年临床结果
葛均波
10:30 AM - FIRE2-DIABETES：评价糖尿病患者中应用FIREBIRD 2钴铬合金雷帕霉素洗脱支架治疗复杂冠脉病变有效性与安全性的前瞻性、多中心注册登记研究 - 6个月临床结果
李妍
Late Breaking Clinical Trials and First Report Investigations II
9:30 AM-11:00 AM, Saturday, March 17th, 2012
Function B, Level 1, CNCC
9:30 AM - CREATE: A Prospective, Large-Scale, Multicenter Registry of EXCEL Biodegradable Polymer Drug-Eluting Stents - Final 5-Year Clinical Results
Yaling Han
10:00 AM - FOCUS: A Prospective, Large-Scale, Multicenter Registry of FIREBIRD 2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent - 2-Year Clinical Results
Junbo Ge
10:30 AM - FIRE2-DIABETES: A Prospective, Multicenter Registry Examining the Efficacy and Safety of FIREBIRD 2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent for the Treatment of Complex Coronary Lesions in Patients with Diabetes - 6-Month Clinical Results
Yan Li

3月17日 星期六 12:40 PM-1:55 PM一层多功能A厅
午间卫星会 雅培血管仪器部主办——DES高峰论坛：分享全球专家观点
1:30 PM - SEEDS注册登记研究进展  
杨跃进

Luncheon Symposium
Sponsored by Abbott Vascular
DES Summit: Sharing Global Expertise
12:40 PM-1:55 PM, Saturday, March 17th, 2012
Function A, Level 1, CNCC
1:30 PM - SEEDS Registry Update
Yuejin Yang

3月17日 星期六 12:40 PM-1:55 PM 三层311A会议室
午间卫星会 微创主办——顺畅心脉，信而有证：FIREBIRD 2支架数据与经验分享
12:45 PM - FOCUS临床研究两年随访结果
葛均波
1:00 PM - FIREBIRD 2钴铬合金西罗莫司洗脱支架在糖尿病复杂冠脉病变中的有效性及安全性研究（FIRE-DIABETES）：6个月随访结果
李妍

Luncheon Symposium
Sponsored by MicroPort
Smoothing the Artery with Proven Evidence: A FIREBIRD 2 Data Review
12:40 PM-1:55 PM, Saturday, March 17th, 2012
Room 311A, Level 3, CNCC
12:45 PM - 2-Year Follow-up Results of FOCUS Study
Junbo Ge
1:00 PM - Efficacy and Safety of FIREBIRD 2 Co-Cr Sirolimus-Eluting Stent in Complex Coronary Lesions for the Treatment of Complex Coronary Lesions in Patients with Diabetes: 6-Month Clinical Results of FIRE2-DIABETES
Yan Li

3月17日 星期六 一层多功能B厅
最新临床试验与特色研究首次公布（三）
3:30 PM - CREST-MI更新：急性ST段抬高型心肌梗死患者中对比CYPHER与ENDEAVOR支架安全性与有效性的多中心、随机对照试验
王乐丰
Late Breaking Clinical Trials and First Report Investigations III
3:30 PM-5:00 PM, Saturday, March 17th, 2012
Function B, Level 1, CNCC
3:30 PM - CREST-MI Update: A Multicenter, Randomized Trial Comparing Safety and Efficacy of CYPHER vs. ENDEAVOR in Patients with Acute ST-Segment Elevation Myocardial Infarction
Lefeng Wang